Sr Accounting Analyst -Cash, Prepaids, Grants at Illumina

Bengaluru, Karnataka, India

Apply Now

Not SpecifiedCompensation

Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, Genomics, HealthcareIndustries

Requirements

Bachelor’s degree in accounting, finance, or equivalent field required (CA, CPA a plus)
Typically requires a minimum of 2 years of related experience; or an advanced degree without experience; or equivalent work experience
Strong understanding of U.S. GAAP
Strong organizational skills and detail-oriented self-starter with the ability to work independently to meet deadlines
Strong interpersonal skills and ability to communicate clearly and concisely both verbally and in writing

Responsibilities

Reconcile cash accounts on a weekly/monthly basis, including generating journal entries and other month-end close duties
Prepare all accounting related to the Company’s derivative instruments including mark-to-market journal entries, record settlement execution and perform variance analysis on a monthly basis
Perform prepaid capitalization review, record required reclass journal entries
Obtain an understanding of the awarded grants/incentives, prepare journal entries and perform balance sheet reconciliations in relation to grant accounting as part of month-end close activities
Maintain Sarbanes-Oxley internal control narratives and testing documentation for areas of responsibilities
Participate in quarterly review and annual audit
Participate in grant/incentive certification activities
Develop, implement and/or maintain one or more accounting systems: Journal entries, General Ledger, Accounts Receivables, Accounts Payable, Revenue Reconciliation, etc
Review and interpret financial reporting requirements, rules and regulations
Balance books and prepare profit and loss, cash flow, income and balance sheet statements
Monitor and develop monthly reports of revenues and expenditures for projects
Provide record of assets, liabilities and other financial transactions
Prepare federal, state and local reports and tax returns as needed
Assist in the setup of processes and procedures that properly capture, track and report revenue, including deferred revenue, in accordance with the company revenue recognition policy
Generate revenue reports for internal and/or external use
Interpret reports and records for managers/stakeholders
Review, track and maintain billing information in the financial systems, ensuring accuracy and compliance with US GAAP and other accounting regulations
Apply company policies and procedures to resolve a variety of issues, determine course of action based on guidelines, and modify processes as required
Build productive working relationships internally and externally, provide standard professional guidance, and collaborate to resolve mutual problems
Work autonomously with little instruction on assignments of moderate scope

Skills

Account Reconciliation

Journal Entries

Month-End Close

Derivative Instruments

Mark-to-Market

Variance Analysis

Prepaid Capitalization

Grant Accounting

Sarbanes-Oxley

SOX Controls

Balance Sheet Reconciliations

Audit Participation

Illumina

Supports genomics startups through funding and resources

About Illumina

Illumina focuses on fostering innovation in the genomics industry by supporting startups through its Illumina Accelerator program. This program helps entrepreneurs create, launch, and grow genomics-focused companies by providing funding and resources. The accelerator operates in two main locations: the San Francisco Bay Area and Cambridge, UK. Illumina Accelerator has successfully invested in 68 genomics startups, which have collectively raised over $1 billion in venture capital. What sets Illumina apart from its competitors is its strong partnership with leading venture capital investors and its dedicated focus on the genomics sector. The goal of Illumina is to build a thriving ecosystem for genomics innovation, enabling new companies to emerge and advance the field.

San Diego, CaliforniaHeadquarters

1998Year Founded

$27.2MTotal Funding

IPOCompany Stage

Venture Capital, BiotechnologyIndustries

5,001-10,000Employees

Risks

Over-reliance on NVIDIA's AI technology may limit flexibility in AI solution adoption.

Standardizing proteomics data across platforms could challenge Illumina's data reliability.

Single-flow-cell NovaSeq X System might cannibalize sales of higher-end models.

Differentiation

Illumina leads in genomic sequencing with advanced AI integration and multiomic data analysis.

The company offers innovative array-based solutions for DNA, RNA, and protein analysis.

Illumina's global expansion includes a new Global Capability Center in Bengaluru.

Upsides

Collaboration with NVIDIA enhances drug discovery and clinical development through AI integration.

Pilot proteomics program with UK Biobank aims to generate crucial reference datasets.

Single-cell sequencing kits make high-throughput sequencing accessible to smaller labs.

Land your dream remote job 3x faster with AI

Try Jobo Free